Revolution Medicines (RVMD) Q2 2025 Earnings

6AugConfirmed
Q4 2024
Q1 2025
Q1 2025
Q2 2025
-1.31
-1.17
-1.03
-0.89

Details

Expected EPS
-1.05
Actual EPS
-1.31
Surprise EPS
-0.26
Surprise Percent
+24.76%

Description

Revolution Medicines (RVMD) has reported earnings of -1.31 per share for Q2 2025.

0 Comments

Share your thoughts